Pixium Vision’s bionic eye on the path to approval
The six month efficacy results of the Feasibility study of Prima Retinal Implant for patients with the dry form of age-related macular degeneration (AMD) were positive.
This retinal implant allows visually impaired patients to see patterns
An electronic chip from the French company Pixium Vision, inserted under the retina to treat age-related macular degeneration, has shown
excellent results in a small clinical trial.
Medtechs: Pixium Vision awakens on the stock market
The company has announced positive results for its “bionic eye” used in the treatment of dry AMD. Its shares gained more than 8% on January 8 on the the Paris Stock Exchange by middle of the day.
University of Pittsburgh Medical Center : A New Frontier in Bionic Vision for Macular Degeneration
An innovative advancement in vision restoration technology is actually
quite small. About 2×2 mm (the size of a pinhead) and as thick as a
human hair to be more precise. Called PRIMA, this bionic retinal implant system is
currently enrolling patients in a clinical trial at the University of
Pittsburgh and UPMC.